Enliven Therapeutics (ELVN) EBIT (2019 - 2026)
Enliven Therapeutics' EBIT was -$37.21 million in Q2 2026, compared with -$28.58 million a year earlier.
Powered by 
Analysis
Enliven Therapeutics (ELVN) EBIT (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Enliven Therapeutics' EBIT was -$124.41 million through Jun 30, 2026; for FY2025, it came in at -$119.66 million.
- In earlier years, EBIT was -$104.55 million in FY2024, -$83.53 million in FY2023, -$38.79 million in FY2022 and -$51.44 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBIT in data going back to Q1 2019.
- Per Business Quant data, ELVN's EBIT in the three quarters before Q2 2026 was -$27.82 million (Q1 2026), -$34.29 million (Q4 2025) and -$25.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.52 Bn | 1,126.11 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 631.39 Bn | 549.92 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 498.93 Bn | 472.04 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 376.05 Bn | 330.42 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 240.27 Bn | 195.67 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.85 Bn | 118.50 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Enliven Therapeutics | 2.79 Bn | 506.02 Mn | - | -37.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.21 Mn |
| Mar 31, 2026 | -27.82 Mn |
| Dec 31, 2025 | -34.29 Mn |
| Sep 30, 2025 | -25.10 Mn |
| Jun 30, 2025 | -28.58 Mn |
| Mar 31, 2025 | -31.69 Mn |
| Dec 31, 2024 | -26.90 Mn |
| Sep 30, 2024 | -27.07 Mn |
| Jun 30, 2024 | -24.60 Mn |
| Mar 31, 2024 | -25.99 Mn |
| Dec 31, 2023 | -22.73 Mn |
| Sep 30, 2023 | -24.25 Mn |
| Jun 30, 2023 | -20.13 Mn |
| Mar 31, 2023 | -16.42 Mn |
| Dec 31, 2022 | -10.16 Mn |
| Sep 30, 2022 | -10.93 Mn |
| Jun 30, 2022 | -9.02 Mn |
| Mar 31, 2022 | -8.68 Mn |
| Dec 31, 2021 | -14.33 Mn |
| Sep 30, 2021 | -13.66 Mn |
API Access
Enliven Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();